Royal Bank of Canada’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.01M | Buy |
5,700
+3,700
| +185% | +$1.32M | ﹤0.01% | 3090 |
|
|
2025
Q4 | $655K | Buy |
+2,000
| New | +$634K | ﹤0.01% | 3960 |
|
|
2025
Q1 | – | Sell |
-472,400
| Closed | -$123M | – | 6776 |
|
|
2024
Q4 | $123M | Buy |
+472,400
| New | +$140M | 0.02% | 499 |
|
|
2021
Q2 | – | Sell |
-200
| Closed | -$50K | – | 7446 |
|
|
2021
Q1 | $50K | Hold |
200
| – | – | ﹤0.01% | 5873 |
|
|
2020
Q4 | $46K | Buy |
+200
| New | +$46.1K | ﹤0.01% | 5687 |
|
|
2020
Q1 | – | Sell |
-12,700
| Closed | -$3.06M | – | 6632 |
|
|
2019
Q4 | $3.06M | Sell |
12,700
-6,300
| -33% | -$1.39M | ﹤0.01% | 2518 |
|
|
2019
Q3 | $3.68M | Buy |
19,000
+9,400
| +98% | +$1.8M | ﹤0.01% | 2291 |
|
|
2019
Q2 | $1.77M | Buy |
+9,600
| New | +$1.72M | ﹤0.01% | 2859 |
|
|
2019
Q1 | – | Sell |
-300
| Closed | -$58K | – | 6772 |
|
|
2018
Q4 | $58K | Buy |
+300
| New | +$58.5K | ﹤0.01% | 5014 |
|
|
2018
Q3 | – | Sell |
-43,500
| Closed | -$8.03M | – | 6685 |
|
|
2018
Q2 | $8.03M | Buy |
43,500
+34,500
| +383% | +$6.1M | ﹤0.01% | 1683 |
|
|
2018
Q1 | $1.53M | Sell |
9,000
-44,300
| -83% | -$8.13M | ﹤0.01% | 2883 |
|
|
2017
Q4 | $9.27M | Buy |
53,300
+4,500
| +9% | +$796K | ﹤0.01% | 1663 |
|
|
2017
Q3 | $9.1M | Hold |
48,800
| – | – | ﹤0.01% | 1602 |
|
|
2017
Q2 | $8.4M | Hold |
48,800
| – | – | ﹤0.01% | 1613 |
|
|
2017
Q1 | $8.01M | Sell |
48,800
-104,000
| -68% | -$17.3M | ﹤0.01% | 1613 |
|
|
2016
Q4 | $22.3M | Sell |
152,800
-3,500
| -2% | -$527K | 0.01% | 995 |
|
|
2016
Q3 | $26.1M | Buy |
156,300
+22,500
| +17% | +$3.8M | 0.01% | 835 |
|
|
2016
Q2 | $20.4M | Sell |
133,800
-7,600
| -5% | -$1.18M | 0.01% | 950 |
|
|
2016
Q1 | $21.2M | Buy |
141,400
+85,900
| +155% | +$12.8M | 0.01% | 890 |
|
|
2015
Q4 | $9.01M | Buy |
55,500
+30,500
| +122% | +$4.79M | 0.01% | 1499 |
|
|
2015
Q3 | $3.46M | Hold |
25,000
| – | – | ﹤0.01% | 1820 |
|
|
2015
Q2 | $3.84M | Buy |
+25,000
| New | +$4M | ﹤0.01% | 1788 |
|
|
2015
Q1 | – | Sell |
-174,700
| Closed | -$27.8M | – | 6100 |
|
|
2014
Q4 | $27.8M | Buy |
174,700
+127,400
| +269% | +$19.9M | 0.02% | 678 |
|
|
2014
Q3 | $6.64M | Buy |
47,300
+10,000
| +27% | +$1.31M | ﹤0.01% | 1443 |
|
|
2014
Q2 | $4.42M | Buy |
37,300
+15,900
| +74% | +$1.84M | ﹤0.01% | 1744 |
|
|
2014
Q1 | $2.64M | Sell |
21,400
-78,400
| -79% | -$9.51M | ﹤0.01% | 2051 |
|
|
2013
Q4 | $11.4M | Sell |
99,800
-76,800
| -43% | -$8.74M | 0.01% | 1113 |
|
|
2013
Q3 | $19.8M | Buy |
176,600
+99,900
| +130% | +$10.8M | 0.02% | 741 |
|
|
2013
Q2 | $7.57M | Buy |
+76,700
| New | +$7.96M | 0.01% | 1193 |
|
Other funds holding AMGN
VCM
VPM
Royal Bank of Canada's AMGN Position: Q1 2026 in Review
Royal Bank of Canada reduced its Amgen (AMGN) stake by 5% in Q1 2026, selling an estimated $83.2M and leaving 4,471,445 shares worth $1.57B. The position accounts for 0.28% of the portfolio, ranked #68.
Royal Bank of Canada first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.68B in Q4 2023. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Royal Bank of Canada held 4,471,445 shares of Amgen worth $1.57B as of Q1 2026.
- Royal Bank of Canada sold 233,485 Amgen shares in Q1 2026, an estimated $83.2M.
- Amgen made up 0.28% of Royal Bank of Canada's portfolio in Q1 2026, its #68 holding.
- Royal Bank of Canada first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Amgen position peaked at $1.68B in Q4 2023.
- 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.